McDonald's shares underperformed in 2024, likely due to the rise of GLP-1 medications. Learn why MCD stock is a Sell.

Cancer researchers found that patients on GLP-1s had significant risk reductions for 10 of 13 obesity-associated cancers.

Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...

Research reveals groundbreaking results about Mounjaro and Ozempic in weight loss treatment. Here's what you need to know ...

For the first time in over a decade, obesity rates have dropped in the United States. A recent study by the CDC showed that ...

CHICAGO — The growing number of US consumers using GLP-1 drugs for weight loss are impacting specific sectors of the consumer ...

With three meds approved for weight management and several on the way, these may make a dent in the obesity epidemic.

随着2024年这些突破性临床试验的相继发表，GLP-1类药物展现出远超预期的治疗潜力。从最初的糖尿病治疗，到减重管理，再到阿尔茨海默病、心血管疾病、慢性肾病、骨关节炎、多囊卵巢综合征等多个重大疾病领域，这类药物正在重新定义现代医学的治疗范式。特别值得 ...

Market News Alerts Updates that DarioHealth Corp. (Nasdaq: DRIO) is taking another bold step into the rapidly growing weight-loss market, now projected to exceed $100 billion annually by 2030. The ...

Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.

This is the beginning of a revolution, and how you engage and how you attack it is going to really set the stage for your ...

Most people have missed a dose of prescription medication at some point. But if you are taking a glucagon-like peptide-1 drug ...